
CardioPrecision
Has developed an innovative and multi-patented technology that allows clinicians to perform minimally invasive interventions through a very small access in the neck.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
* | N/A | Early VC | |
Total Funding | 000k |
Related Content
CardioPrecision specializes in developing advanced medical devices for cardiothoracic surgery, focusing on minimally invasive techniques. The company's flagship products include the CardioPrecision Retractor and single-use Retractor and Accessories, which allow surgeons to perform complex procedures through a small incision in the skin crease of the neck. This technology is particularly beneficial for endoscopic harvesting of the radial artery or long saphenous vein, offering a less invasive alternative to traditional methods. CardioPrecision operates in the global healthcare market, serving cardiac and thoracic surgeons, hospitals, and healthcare institutions. The business model revolves around the sale of its patented surgical tools and accessories, generating revenue through direct sales and partnerships with medical distributors. The company has secured multiple patents, including a new TMVR method in the US, and continues to innovate in the field of endoscopic vessel harvesting.
Keywords: cardiothoracic surgery, minimally invasive, medical devices, endoscopic harvesting, radial artery, saphenous vein, patented technology, quick recovery, global healthcare, surgical tools.